What is your approach to adjuvant RT or chemoRT in LS-SCLC s/p lobectomy with N1 disease?

I am unaware of any data suggesting a benefit of adjuvant RT in this scenario assuming completely resected. In the absence of data, I would not recommend adjuvant RT in an N1 patient, rationale below. Adjuvant systemic therapy would be strongly recommended.

My thought process to this is that SCLC ha...

This was thought to be an early-stage disease (T1-T2N0M0) and the decision was made to undergo lobectomy + hilar/mediastinal LN assessment. This is certainly an option based on NCCN guidelines. After surgery, there was an occult N1 node seen on the path. These patients are still at very high risk of...